Cargando…
Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients
AIMS: Mid- and long-term safety and efficacy of the Absorb bioresorbable vascular scaffold (BVS) have been studied in randomised trials; however, most were not individually powered for clinical endpoints. We performed a weighted meta-analysis comparing mid- and long-term outcomes in patients treated...
Autores principales: | Elias, J., van Dongen, I. M., Kraak, R. P., Tijssen, R. Y. G., Claessen, B. E. P. M., Tijssen, J. G. P., de Winter, R. J., Piek, J. J, Wykrzykowska, J. J., Henriques, J. P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513992/ https://www.ncbi.nlm.nih.gov/pubmed/28612280 http://dx.doi.org/10.1007/s12471-017-1008-x |
Ejemplares similares
-
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020) -
Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015) -
Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017) -
The Absorb bioresorbable vascular scaffold in real-world practice: long-term follow-up of the AMC Single Centre Real World PCI Registry
por: Tijssen, R. Y. G., et al.
Publicado: (2020) -
Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
por: Dalos, Daniel, et al.
Publicado: (2016)